Renub

    United States Biopsy Market, Size, Forecast 2023-2028, Industry Trends, Growth, Impact of Inflation, Opportunity Company Analysis

    Excel: 8 Hours
    PDF: 24 Hours
    Feb 2023
    Pages: 150

    United States Biopsy Market Outlook

    United States Biopsy Market is expected to reach US$ 21.40 Billion by 2028, according to Renub Research. A biopsy is a medical procedure in which a small tissue sample is removed from the body for examination, typically to diagnose or monitor a disease or condition. Biopsies in the United States are commonly performed by healthcare professionals such as pathologists, surgeons, or radiologists. The biopsy market in the United States is a growing due to the increasing demand for early and accurate diagnoses of various medical conditions.

     

    united-states-biopsy-market


    The market includes a variety of biopsy products and services, including biopsy needles, biopsy forceps, imaging guidance systems, and laboratory services. In recent years, the market has seen growth in the use of minimally invasive biopsy techniques, such as fine needle aspiration and core needle biopsy, as well as advances in imaging technologies, such as ultrasound and magnetic resonance imaging that help guide biopsy procedures. Additionally, the aging population and increasing rates of chronic diseases are contributing to the growth of the biopsy market in the United States.


    USA Biopsy Market will grow with a 4.50% CAGR during the Forecast Period

    Despite the growth of the biopsy market in the United States, a few challenges need to be addressed. One of the significant challenges is the need for more skilled professionals, such as pathologists, who analyze the biopsy samples and diagnose. Another challenge is the high cost of biopsy procedures, which can be a barrier for some patients, especially those without insurance. The United States Biopsy Industry was US$ 16.43 Billion in 2022.


    Breast Cancer is the most prevalent cancer on the list, with 290,560 new cases anticipated in the U.S in 2022

    In the United States, biopsy procedures are commonly performed to diagnose or monitor different types of cancer. Some of the most common cancers for which biopsy procedures are performed include Breast Cancer, prostate, lung, liver, thyroid, kidney, colorectal, and melanoma. The most common type of biopsy procedure performed for breast cancer is a fine needle aspiration or core needle biopsy. A biopsy is often used to confirm a diagnosis of breast cancer. The breast cancer biopsy market in the United States is a significant and growing market due to the increasing incidence of breast cancer and advancements in biopsy techniques. According to our reports, the U.S. breast cancer biopsy market is expected to grow significantly in the coming years. The market growth can be attributed to increasing demand for early diagnosis, raising awareness about breast cancer, and advancements in biopsy technology.


    Another factor contributing to the growth of the biopsy market in the United States is the aging population and the increasing incidence of chronic diseases. As people age, they are more likely to develop chronic conditions, such as cancer, which require an early and accurate diagnosis. The increasing incidence of cancer has led to a higher demand for biopsy procedures, which has driven the biopsy market growth.


    Key Companies & Market Insights

    The biopsy market in the United States is highly competitive, with many players offering various products and services. Some of the leading players in the market include Becton, Dickinson & Company, Braun Melsungen AG, Cardinal Health, Inc., Medtronic Plc., Hologic, Inc., Bio-Rad Laboratories Inc, Quest Diagnostics, Thermo Fisher Scientific Inc, Roche Diagnostics and Myriad Genetics Inc. These companies are investing heavily in research and development to develop new biopsy technologies and products to meet the growing demand. They are also working to improve the accuracy and precision of biopsy procedures and reduce the risk of complications.


    For instance, Epic Biosciences announced the availability of a multi-analyte liquid biopsy for metastatic breast cancer in January 2022. DefineMBC from the company offers both cell-free and cell-based analyses.


    In conclusion, the biopsy market in the United States is a growing industry driven by the increasing demand for early and accurate diagnoses of various medical conditions. With the advancements in technology and the rising incidence of chronic diseases, the market is expected to grow in the coming years. However, companies in the biopsy market will need to address the challenges of a shortage of skilled professionals and high costs to continue to grow and succeed.


    Renub Research report titled “United States Biopsy Market, Volume & Forecast by Segments (Breast Cancer, Prostate Cancer, Lung Cancer, Liver Cancer, Thyroid Cancer, Kidney Cancer, Colorectal Cancer and Melanoma Cancer) Cancer, Companies (Becton, Dickinson & Company, Braun Melsungen AG, Cardinal Health, Inc., Medtronic Plc., Hologic, Inc., Bio-Rad Laboratories Inc, Quest Diagnostics, Thermo Fisher Scientific Inc, Roche Diagnostics and Myriad Genetics Inc)” provides a complete analysis of the United States Biopsy Market and Volume.

     

    united-states-biopsy-market-share


    United States Biopsy Volume Insights - In this report, we have Fragmented Cancer by Biopsy Volume into 8 parts

    1.    Breast Cancer
    2.    Prostate Cancer
    3.    Lung Cancer
    4.    Liver Cancer
    5.    Thyroid Cancer
    6.    Kidney Cancer
    7.    Colorectal Cancer
    8.    Melanoma Cancer


    United States Biopsy Market Insights: In this report, we have Categorized the Biopsy Market into 8 parts by Cancer Type

    1.    Breast Cancer
    2.    Prostate Cancer
    3.    Lung Cancer
    4.    Liver Cancer
    5.    Thyroid Cancer
    6.    Kidney Cancer
    7.    Colorectal Cancer
    8.    Melanoma Cancer


    Company Insights:

    •    Overview
    •    Company Initiatives
    •    Sales Analysis


    Key Companies Covered in the Report:

    1.    Becton, Dickinson & Company
    2.    Braun Melsungen AG
    3.    Cardinal Health, Inc.
    4.    Medtronic Plc.
    5.    Hologic, Inc.
    6.    Bio-Rad Laboratories Inc
    7.    Quest Diagnostics
    8.    Thermo Fisher Scientific Inc
    9.    Roche Diagnostics
    10.    Myriad Genetics Inc


    Report Details:

    Report Features Details
    Base Year 2022
    Historical Period 2018 - 2022
    Forecast Period 2023 - 2028
    Market US$ Billion
    Segment Covered Breast Cancer, Prostate Cancer, Lung Cancer, Liver Cancer, Thyroid Cancer, Kidney Cancer, Colorectal Cancer and Melanoma Cancer
    Companies Covered Becton, Dickinson & Company, Braun Melsungen AG, Cardinal Health, Inc., Medtronic Plc., Hologic, Inc., Bio-Rad Laboratories Inc, Quest Diagnostics, Thermo Fisher Scientific Inc, Roche Diagnostics and Myriad Genetics Inc
    Customization Scope 20% Free Customization
    Post-Sale Analyst Support 1 Year (52 Weeks)
    Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on request)

    1.    Introduction

    2.    Research & Methodology

    3.    Executive Summary

    4.    Market Dynamics

    4.1    Growth Drivers
    4.2    Challenges


    5.    Biopsy Devices: Competitive Assessment

    5.1    Assessment by Product Type

    5.1.1    Core Biopsy Devices
    5.1.2    Aspiration Biopsy Needles
    5.1.3    Vacuum Assisted Biopsy Devices

    5.2    Assessment by Technique

    5.2.1    Ultrasound-guided Biopsy
    5.2.2    Stereotactic-guided Biopsy
    5.2.3    MRI-guided Biopsy


    6.    United States Cancer Cases

    6.1    Total Number of Cancer Cases

    6.1.1    Breast Cancer
    6.1.2    Prostate Cancer
    6.1.3    Lung Cancer
    6.1.4    Liver Cancer
    6.1.5    Thyroid Cancer
    6.1.6    Kidney Cancer
    6.1.7    Colorectal Cancer 
    6.1.8    Melanoma Cancer

    6.2    Cancer Cases by Gender

    6.3    Cancer Cases by Age Group


    7.    United States Biopsy Market & Volume Analysis

    7.1    Market
    7.2    Volume


    8.    Market & Volume Share – United States Biopsy Analysis

    8.1    Market Share
    8.2    Volume Share


    9.    Segment – United States Biopsy Market

    9.1    Prostate Cancer Biopsy

    9.1.1    Market
    9.1.2    Volume

    9.2    Breast Cancer Biopsy

    9.2.1    Market
    9.2.2    Volume

    9.3    Lung Cancer Biopsy

    9.3.1    Market
    9.3.2    Volume

    9.4    Liver Cancer Biopsy

    9.4.1    Market
    9.4.2    Volume

    9.5    Thyroid Cancer Biopsy

    9.5.1    Market
    9.5.2    Volume

    9.6    Kidney Cancer Biopsy

    9.6.1    Market
    9.6.2    Volume

    9.7    Colon & Rectum Cancer Biopsy

    9.7.1    Market
    9.7.2    Volume

    9.8    Melanoma Skin Cancer Biopsy

    9.8.1    Market
    9.8.2    Volume


    10.    Porters Five Forces

    10.1    Bargaining Power of Buyers
    10.2    Bargaining Power of Suppliers
    10.3    Degree of Competition
    10.4    Threat of New Entrants
    10.5    Threat of Substitutes


    11.    Merger & Acquisition

    12.    Company Analysis

    12.1    Becton, Dickinson & Company

    12.1.1    Overview
    12.1.2    Recent Developments
    12.1.3    Revenue

    12.2    B. Braun Melsungen AG (Germany)

    12.2.1    Overview
    12.2.2    Recent Developments
    12.2.3    Revenue

    12.3    Cardinal Health, Inc.

    12.3.1    Overview
    12.3.2    Recent Developments
    12.3.3    Revenue

    12.4    Medtronic Plc.

    12.4.1    Overview
    12.4.2    Recent Developments
    12.4.3    Revenue

    12.5    Hologic, Inc.

    12.5.1    Overview
    12.5.2    Recent Developments
    12.5.3    Revenue

    12.6    Bio-Rad Laboratories Inc

    12.6.1    Overview
    12.6.2    Recent Developments
    12.6.3    Revenue

    12.7    Quest Diagnostics

    12.7.1    Overview
    12.7.2    Recent Developments
    12.7.3    Revenue

    12.8    Thermo Fisher Scientific Inc

    12.8.1    Overview
    12.8.2    Recent Developments
    12.8.3    Revenue

    12.9    Roche Diagnostics

    12.9.1    Overview
    12.9.2    Recent Developments
    12.9.3    Revenue

    12.10    Myriad Genetics Inc

    12.10.1    Overview
    12.10.2    Recent Developments
    12.10.3    Revenue


    List of Figures:

    Figure-01:    United States – Biopsy Market (Billion US$), 2018 – 2022
    Figure-02:    United States – Forecast for Biopsy Market (Billion US$), 2023 – 2028
    Figure-03:    United States – Biopsy Volume (Thousand), 2018 – 2022
    Figure-04:    United States – Forecast for Biopsy Volume (Thousand), 2023 – 2028
    Figure-05:    United States – Prostate Cancer Biopsy Market (Million US$), 2018 – 2022
    Figure-06:    United States – Forecast for Prostate Cancer Biopsy Market (Million US$), 2023 – 2028
    Figure-07:    United States – Prostate Cancer Biopsy Volume (Thousand), 2018 – 2022
    Figure-08:    United States – Forecast for Prostate Cancer Biopsy Volume (Thousand), 2023 – 2028
    Figure-09:    United States – Breast Cancer Biopsy Market (Million US$), 2018 – 2022
    Figure-10:    United States – Forecast for Breast Cancer Biopsy Market (Million US$), 2023 – 2028
    Figure-11:    United States – Breast Cancer Biopsy Volume (Thousand), 2018 – 2022
    Figure-12:    United States – Forecast for Breast Cancer Biopsy Volume (Thousand), 2023 – 2028
    Figure-13:    United States – Lung Cancer Biopsy Market (Million US$), 2018 – 2022
    Figure-14:    United States – Forecast for Lung Cancer Biopsy Market (Million US$), 2023 – 2028
    Figure-15:    United States – Lung Cancer Biopsy Volume (Thousand), 2018 – 2022
    Figure-16:    United States – Forecast for Lung Cancer Biopsy Volume (Thousand), 2023 – 2028
    Figure-17:    United States – Liver Cancer Biopsy Market (Million US$), 2018 – 2022
    Figure-18:    United States – Forecast for Liver Cancer Biopsy Market (Million US$), 2023 – 2028
    Figure-19:    United States – Liver Cancer Biopsy Volume (Thousand), 2018 – 2022
    Figure-20:    United States – Forecast for Liver Cancer Biopsy Volume (Thousand), 2023 – 2028
    Figure-21:    United States – Thyroid Cancer Biopsy Market (Million US$), 2018 – 2022
    Figure-22:    United States – Forecast for Thyroid Cancer Biopsy Market (Million US$), 2023 – 2028
    Figure-23:    United States – Thyroid Cancer Biopsy Volume (Thousand), 2018 – 2022
    Figure-24:    United States – Forecast for Thyroid Cancer Biopsy Volume (Thousand), 2023 – 2028
    Figure-25:    United States – Kidney Cancer Biopsy Market (Million US$), 2018 – 2022
    Figure-26:    United States – Forecast for Kidney Cancer Biopsy Market (Million US$), 2023 – 2028
    Figure-27:    United States – Kidney Cancer Biopsy Volume (Thousand), 2018 – 2022
    Figure-28:    United States – Forecast for Kidney Cancer Biopsy Volume (Thousand), 2023 – 2028
    Figure-29:    United States – Colon & Rectum Cancer Biopsy Market (Million US$), 2018 – 2022
    Figure-30:    United States – Forecast for Colon & Rectum Cancer Biopsy Market (Million US$), 2023 – 2028
    Figure-31:    United States – Colon & Rectum Cancer Biopsy Volume (Thousand), 2018 – 2022
    Figure-32:    United States – Forecast for Colon & Rectum Cancer Biopsy Volume (Thousand), 2023 – 2028
    Figure-33:    United States – Melanoma Skin Cancer Biopsy Market (Million US$), 2018 – 2022
    Figure-34:    United States – Forecast for Melanoma Skin Cancer Biopsy Market (Million US$), 2023 – 2028
    Figure-35:    United States – Melanoma Skin Cancer Biopsy Volume (Thousand), 2018 – 2022
    Figure-36:    United States – Forecast for Melanoma Skin Cancer Biopsy Volume (Thousand), 2023 – 2028
    Figure-37:    Becton, Dickinson & Company – Global Revenue (Billion US$), 2018 – 2022
    Figure-38:    Becton, Dickinson & Company – Forecast for Global Revenue (Billion US$), 2023 – 2028
    Figure-39:    B. Braun Melsungen AG (Germany) – Global Revenue (Billion US$), 2018 – 2022
    Figure-40:    B. Braun Melsungen AG (Germany) – Forecast for Global Revenue (Billion US$), 2023 – 2028
    Figure-41:    Cardinal Health, Inc. – Global Revenue (Billion US$), 2018 – 2022
    Figure-42:    Cardinal Health, Inc. – Forecast for Global Revenue (Billion US$), 2023 – 2028
    Figure-43:    Medtronic Plc. – Global Revenue (Billion US$), 2018 – 2022
    Figure-44:    Medtronic Plc. – Forecast for Global Revenue (Billion US$), 2023 – 2028
    Figure-45:    Hologic, Inc. – Global Revenue (Million US$), 2018 – 2022
    Figure-46:    Hologic, Inc. – Forecast for Global Revenue (Million US$), 2023 – 2028
    Figure-47:    Bio-Rad Laboratories Inc – Global Revenue (Million US$), 2018 – 2022
    Figure-48:    Bio-Rad Laboratories Inc – Forecast for Global Revenue (Million US$), 2023 – 2028
    Figure-49:    Quest Diagnostics – Global Revenue (Billion US$), 2018 – 2022
    Figure-50:    Quest Diagnostics – Forecast for Global Revenue (Billion US$), 2023 – 2028
    Figure-51:    Thermo Fisher Scientific Inc – Global Revenue (Billion US$), 2018 – 2022
    Figure-52:    Thermo Fisher Scientific Inc – Forecast for Global Revenue (Billion US$), 2023 – 2028
    Figure-53:    Roche Diagnostics – Global Revenue (Billion US$), 2018 – 2022
    Figure-54:    Roche Diagnostics – Forecast for Global Revenue (Billion US$), 2023 – 2028
    Figure-55:    Myriad Genetics Inc – Global Revenue (Million US$), 2018 – 2022
    Figure-56:    Myriad Genetics Inc – Forecast for Global Revenue (Million US$), 2023 – 2028


    List of Tables:

    Table-1:    United States – Biopsy Market Share by Cancer Type (Percent), 2018 – 2022
    Table-2:    United States – Forecast for Biopsy Market Share by Cancer Type (Percent), 2023 – 2028
    Table-3:    United States – Biopsy Volume Share by Cancer Type (Percent), 2018 – 2022
    Table-4:    United States – Forecast for Biopsy Volume Share by Cancer Type (Percent), 2023 – 2028

    • Description
      Price
    • Chapter 1, 4 & 5     Pages : 15
      $400
    •      Pages : 12
      $300
    • Chapter 6     Pages : 8
      $300
    • Chapter 7     Pages : 4
      $200
    • Chapter 9     Pages : 32
      $1,500
    • Chapter 10     Pages : 5
      $300
    • Chapter 11     Pages : 2
      $200
    • Chapter 12.1     Pages : 5
      $150
    • Chapter 12.2     Pages : 5
      $150
    • Chapter 12.3     Pages : 5
      $150
    • Chapter 12.4     Pages : 5
      $150
    • Chapter 12.5     Pages : 5
      $150
    • Chapter 12.6     Pages : 5
      $150
    • Chapter 12.7     Pages : 5
      $150
    • Chapter 12.8     Pages : 5
      $150
    • Chapter 12.9     Pages : 5
      $150
    • Chapter 12.10     Pages : 5
      $150

    Related Reports